You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Hepatitis C virus therapy to date
Contributor:
Foster, Graham;
Mathurin, Philippe
Published:
SAGE Publications, 2008
Published in:
Antiviral Therapy, 13 (2008) 1_suppl, Seite 3-8
Language:
English
DOI:
10.1177/135965350801301s04
ISSN:
1359-6535;
2040-2058
Origination:
Footnote:
Description:
Chronic hepatitis C is a major contributor to cirrhosis and hepatocellular cancer worldwide, justifying the considerable research effort aimed at understanding the disease and refining its treatment. As a result, significant therapeutic advances have been made in the last decade, particularly with regard to the development of pegylated interferons and ribavirin. This review will discuss the physical properties, pharmacokinetics, viral kinetics and side-effect profiles of the different treatment options and how they have improved, culminating in the use of pegylated interferon and ribavirin combination therapy as the current standard of care.